Back

TGFB1 rs8179181 polymorphism is reproducibly associated with Parkinson's disease in a Spanish population

Comino, A.; Antolin-Vallespin, M.; Lopez-Benito, A.; Munoz, G.; del Castillo, F. J.; Vela, L.; Martinez-Castrillo, J. C.; Sanchez-Capelo, A.

2022-07-11 neurology
10.1101/2022.07.09.22277447 medRxiv
Show abstract

There is evidence that transforming growth factor (TGF)-{beta} signaling participates in the pathology of Parkinsons disease (PD). Dampened TGF-{beta} signaling in Smad3- or T{beta}RII-deficient mice leads to the appearance of -synuclein inclusions in the brain, as well as dopaminergic, motor, and cognitive deficits. Accordingly, we hypothesized that genetic variants of TGFB/SMAD could be risk factors for PD in humans. Here, we present two independent case-control studies aimed at evaluating the association between genetic variants of six genes related to TGF-{beta} signaling (TGFB1, TGFB2, TGFBRI, TGFBRII, SMAD3 and SMAD2) and the development of sporadic PD. A total of 275 unrelated Spanish Caucasian individuals were included in the study (141 cases and 134 controls), with 132 individuals in the discovery phase and 143 individuals in the replication phase. Next-generation sequencing identified a total of 409 variants in the coding, splicing, and untranslated regions of these genes. Analysis of common variants in the discovery phase revealed an association between PD and the TGFB1 rs8179181 variant, which was further confirmed in the replication phase [odds ratio (OR) 0.48, 95% confidence interval (CI) 0.32-0.73, p = 0.00057). A weak association of the SMAD3 rs11556089 polymorphism with PD was also detected (OR 0.49, 95% CI 0.26-0.93, p = 0.0375). Seven haplotypes were identified; however, there were no significant differences in their frequencies between patients with PD and controls. In conclusion, both the discovery and replication phases of this study suggest that the rs8179181 variant of TGFB1 represents a novel susceptibility locus for PD. HIGHLIGHTSO_LIDeficient TGF-{beta} signalling via Smad3 induces the formation of -synuclein aggregates and a parkinsonian pathology in mice. C_LIO_LITGFB1, TGFB2, TGFBRI, TGFBRII, SMAD3 and SMAD2 genes were sequenced to search for associations of their allelic variants with idiopathic PD. C_LIO_LITwo independent case-control studies of Spanish Caucasian individuals identified 409 genetic variants in their coding, splicing and UTR regions. C_LIO_LIThe rs8179181 SNP in TGFB1 was reproducibly associated with idiopathic PD, representing a novel PD susceptibility locus. C_LI

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Journal of Parkinson's Disease
13 papers in training set
Top 0.1%
11.8%
2
PLOS ONE
5266 papers in training set
Top 20%
8.8%
3
npj Parkinson's Disease
105 papers in training set
Top 0.5%
5.4%
4
Acta Neuropathologica
58 papers in training set
Top 0.3%
5.4%
5
Molecular Neurobiology
53 papers in training set
Top 0.2%
4.3%
6
Neurobiology of Aging
107 papers in training set
Top 0.5%
4.0%
7
Parkinsonism & Related Disorders
25 papers in training set
Top 0.2%
4.0%
8
Molecular Neurodegeneration
55 papers in training set
Top 0.6%
3.4%
9
Acta Neuropathologica Communications
89 papers in training set
Top 0.7%
3.2%
50% of probability mass above
10
Scientific Reports
3612 papers in training set
Top 34%
3.2%
11
Journal of Parkinson’s Disease
12 papers in training set
Top 0.1%
3.2%
12
Movement Disorders
71 papers in training set
Top 0.4%
3.2%
13
Clinical and Translational Medicine
31 papers in training set
Top 0.1%
3.2%
14
Annals of Neurology
64 papers in training set
Top 0.5%
3.2%
15
International Journal of Molecular Sciences
494 papers in training set
Top 6%
2.1%
16
Biomedicines
67 papers in training set
Top 1%
1.5%
17
Neurology Genetics
15 papers in training set
Top 0.1%
1.4%
18
Journal of Translational Medicine
57 papers in training set
Top 1.0%
1.4%
19
Journal of Neurology
28 papers in training set
Top 0.6%
1.4%
20
Cells
249 papers in training set
Top 5%
1.1%
21
European Journal of Neurology
22 papers in training set
Top 0.5%
1.1%
22
BMC Cancer
67 papers in training set
Top 2%
1.1%
23
Neurology
50 papers in training set
Top 1%
1.0%
24
Journal of Medical Genetics
29 papers in training set
Top 0.5%
1.0%
25
Neuropathology and Applied Neurobiology
15 papers in training set
Top 0.4%
0.8%
26
Scientific Data
209 papers in training set
Top 3%
0.8%
27
Translational Psychiatry
260 papers in training set
Top 4%
0.6%
28
The Journal of Pathology
26 papers in training set
Top 1%
0.6%
29
EMBO Molecular Medicine
95 papers in training set
Top 4%
0.6%
30
Genes
144 papers in training set
Top 5%
0.6%